InvestorsHub Logo
Followers 56
Posts 1134
Boards Moderated 1
Alias Born 01/13/2017

Re: skitahoe post# 63780

Thursday, 03/02/2017 5:06:53 PM

Thursday, March 02, 2017 5:06:53 PM

Post# of 203913
I think the point from the conference yesterday is the OWCP would like to go toe-to-toe with GW*H on the Delivery Systems.

GW*H has a new inhaler type device, like the kind for certain asthma meds.

OWCP has the topical cream, sublingual tablet, and others.

GW*H will have the right delivery system for meds which you want in the blood system via the lungs, while OWCP will go topical and via the blood system via the mouth.

Different delivery systems for different indications.

Know What You Own. My posts should not be construed as investment advice.